| Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients V Gopalakrishnan, CN Spencer, L Nezi, A Reuben, MC Andrews, ... Science 359 (6371), 97-103, 2018 | 3828 | 2018 |
| Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation FM Marty, P Ljungman, RF Chemaly, J Maertens, SS Dadwal, RF Duarte, ... New England Journal of Medicine 377 (25), 2433-2444, 2017 | 971 | 2017 |
| A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID‐19) pandemic: an international collaborative group HO Al‐Shamsi, W Alhazzani, A Alhuraiji, EA Coomes, RF Chemaly, ... The oncologist 25 (6), e936-e945, 2020 | 776 | 2020 |
| Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003) G Chamilos, M Luna, RE Lewis, GP Bodey, R Chemaly, JJ Tarrand, ... haematologica 91 (7), 986-989, 2006 | 654 | 2006 |
| Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial FM Marty, P Ljungman, GA Papanicolaou, DJ Winston, RF Chemaly, ... The Lancet infectious diseases 11 (4), 284-292, 2011 | 399 | 2011 |
| Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation RF Chemaly, AJ Ullmann, S Stoelben, MP Richard, M Bornhäuser, ... New England Journal of Medicine 370 (19), 1781-1789, 2014 | 392 | 2014 |
| Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center RF Chemaly, S Ghosh, GP Bodey, N Rohatgi, A Safdar, MJ Keating, ... Medicine 85 (5), 278-287, 2006 | 366 | 2006 |
| Posaconazole: a broad-spectrum triazole antifungal HA Torres, RY Hachem, RF Chemaly, DP Kontoyiannis, II Raad The Lancet infectious diseases 5 (12), 775-785, 2005 | 351 | 2005 |
| Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study A Sharma, NS Bhatt, A St Martin, MB Abid, J Bloomquist, RF Chemaly, ... The Lancet Haematology 8 (3), e185-e193, 2021 | 327 | 2021 |
| Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled … DJ Winston, JAH Young, V Pullarkat, GA Papanicolaou, R Vij, E Vance, ... Blood, The Journal of the American Society of Hematology 111 (11), 5403-5410, 2008 | 271 | 2008 |
| Management of RSV infections in adult recipients of hematopoietic stem cell transplantation JN Shah, RF Chemaly Blood, The Journal of the American Society of Hematology 117 (10), 2755-2763, 2011 | 267 | 2011 |
| Utility of Galactomannan Enzyme Immunoassay and (1,3) β-d-Glucan in Diagnosis of Invasive Fungal Infections: Low Sensitivity for Aspergillus fumigatus Infection … RY Hachem, DP Kontoyiannis, RF Chemaly, Y Jiang, R Reitzel, I Raad Journal of Clinical Microbiology 47 (1), 129-133, 2009 | 256 | 2009 |
| Cytomegalovirus diseases after hematopoietic stem cell transplantation: a mini-review EJ Ariza-Heredia, L Nesher, RF Chemaly Cancer letters 342 (1), 1-8, 2014 | 206 | 2014 |
| Venous thrombosis associated with peripherally inserted central catheters: a retrospective analysis of the Cleveland Clinic experience RF Chemaly, J Barbara de Parres, SJ Rehm, KA Adal, MV Lisgaris, ... Clinical infectious diseases 34 (9), 1179-1183, 2002 | 206 | 2002 |
| Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies RF Chemaly, DP Shah, MJ Boeckh Clinical infectious diseases 59 (suppl_5), S344-S351, 2014 | 203 | 2014 |
| The role of the healthcare environment in the spread of multidrug-resistant organisms: update on current best practices for containment RF Chemaly, S Simmons, C Dale Jr, SS Ghantoji, M Rodriguez, J Gubb, ... Therapeutic advances in infectious disease 2 (3-4), 79-90, 2014 | 193 | 2014 |
| A randomized, double-blind, placebo-controlled phase 3 trial of oral brincidofovir for cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplantation FM Marty, DJ Winston, RF Chemaly, KM Mullane, TB Shore, ... Biology of Blood and Marrow Transplantation 25 (2), 369-381, 2019 | 185 | 2019 |
| Colistin Is Effective in Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa in Cancer Patients RY Hachem, RF Chemaly, CA Ahmar, Y Jiang, MR Boktour, GA Rjaili, ... Antimicrobial agents and chemotherapy 51 (6), 1905-1911, 2007 | 178 | 2007 |
| How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients F El Chaer, DP Shah, RF Chemaly Blood, The Journal of the American Society of Hematology 128 (23), 2624-2636, 2016 | 175 | 2016 |
| Definitions of resistant and refractory cytomegalovirus infection and disease in transplant recipients for use in clinical trials RF Chemaly, S Chou, H Einsele, P Griffiths, R Avery, RR Razonable, ... Clinical Infectious Diseases 68 (8), 1420-1426, 2019 | 171 | 2019 |
